On demand webinars
60 matching events
31 Mar 2020
Webinar
Debate session – Should ocrelizumab and cladribine be treated in the same way as alemtuzumab in terms of risk of COVID-19?
25 Mar 2020
Webinar
AHSCT for highly active and rapidly evolving severe MS during the COVID-19 pandemic